QA: Tenax Therapeutics INC in us_pharma/2016

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0000034956_2017_Tenax_Therapeutics_INC.pdf

Logs

warning Missing logo subcommand.report {}

Graph

Absolute values for 0000034956, Tenax Therapeutics INC

  xvar xval
0 AssetsCurrent 13,628,175
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 19,105
3 remainder_Assets 9,692,895
4 LiabilitiesCurrent 6,199,237
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 7,847,974
9 ResearchAndDevelopmentExpense 13,105,600
10 remainder_Expenses 21,130,121
11 remainder_Revenues 36,163
12 remainder_NetIncome 587,364
13 remainder_ComprehensiveNetIncome 87,737,084
  yvar yval
0 Assets 23,340,175
1 Liabilities 6,199,237
2 Expenses 42,083,695
3 Revenues 36,163
4 StockholdersEquity 17,140,938
5 NetIncome -41,460,168
6 ComprehensiveNetIncome 2,408,374
7 BaseVar 79,991,859
8 EconomicCapitalRatiobeforeLimitedLiability 2.69
9 EconomicCapitalRatio 3.48

Edgar->Model Mapping

Feature Distribution

Change over Time